COMMUNIQUÉS West-GlobeNewswire

ChromaDex and Watsons Expand TRU NIAGEN® Retail Partnership Through 2021

07/08/2018 - 12:30

Global partnership commits to significant growth of TRU NIAGEN® including launch in Turkey IRVINE, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical [...]

Nightstar Therapeutics to Present at Wedbush PacGrow Healthcare Conference

07/08/2018 - 12:05

WALTHAM, Mass. and LONDON, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Nightstar Therapeutics plc (NASDAQ: NITE), a clinical-stage gene therapy company developing treatments for rare inherited retinal diseases, today announced [...]

Invitation: Terveystalo Half Year result audiocast and conference call on 17 August 2018

07/08/2018 - 12:00

Terveystalo Plc will publish its Half Year report for 2018 on Friday, 17 August 2018 at approximately 9:00 am EEST. The company will host an audiocast and conference call in English on17 August at 12:30 Finnish time ( [...]

BioCryst Reports Second Quarter 2018 Financial Results

07/08/2018 - 12:00

RESEARCH TRIANGLE PARK, N.C., Aug. 07, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced today financial results for the second quarter ended June 30, 2018. “Building on the clear direction [...]

Fennec Pharmaceuticals Receives Positive Opinion on the Pediatric Investigation Plan From European Medicines Agency for PEDMARK(TM) and Confirmation of Eligibility for a Pediatric Use Marketing Authorization

07/08/2018 - 12:00

RESEARCH TRIANGLE PARK, N.C., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today announced that the Pediatric Committee (PDCO) of the [...]

Shire plc : Director/PDMR Shareholding

07/08/2018 - 12:00

Director/PDMR Shareholding August 7, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) Notification of transactions by persons discharging managerial responsibilities 1. Details of the person discharging [...]

G1 Therapeutics to Present at Wedbush PacGrow Healthcare Conference on August 14, 2018

07/08/2018 - 12:00

RESEARCH TRIANGLE PARK, N.C., Aug. 07, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that Chief Medical Officer Raj Malik, M.D., will present a company [...]

EnvoyAI Partners with Mach7 Technologies to expand AI to Enterprise Imaging, VNA, and PACS

07/08/2018 - 12:00

CAMBRIDGE, Mass., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Artificial intelligence (AI) platform provider, EnvoyAI, has entered into a distribution deal with Mach7 Technologies, a leading enterprise imaging solution provider. [...]

Introducing New Weight Loss and Wellness Center: Healing at Sweetgrass

07/08/2018 - 11:00

Practice provides patients with the utmost care in a private and relaxing environment CHARLESTON, S.C., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Healing at Sweetgrass, led by medical director Michael Bauerschmidt, MD, is a [...]

Over 100 Physicians at the Florida Medical Association Conference Establish HealthLynked Profiles

07/08/2018 - 11:00

NAPLES, Fla., Aug. 07, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK) took center stage at the Florida Medical Association conference in Orlando, Florida, August 3-4, 2018. The conference resulted in over 100 [...]

Transactions in relation to share buyback program

07/08/2018 - 10:27

Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

Tecan schedules conference call on August 16th to discuss half year 2018 financial results

07/08/2018 - 10:16

Männedorf, Switzerland, August 7, 2018 - The Tecan Group AG (SIX Swiss Exchange: TECN) will hold a conference call to discuss the financial results for the first half year 2018 on Thursday, August 16th, 2018 at 10:00 [...]

Curetis Expands Geographic Presence with Entry into Northern African and Latin American Markets

07/08/2018 - 09:30

Curetis Expands Geographic Presence with Entry into Northern African and Latin American Markets New Unyvero distribution partnerships in Egypt, Mexico, and Uruguay Contractual commitments for 45 Unyvero Systems [...]

Curetis to Report its Half-Year Results 2018 on August 14, 2018

07/08/2018 - 08:46

Curetis to Report its Half-Year Results 2018 on August 14, 2018 - Company will host earnings conference call and webcast Amsterdam, the Netherlands, Holzgerlingen, Germany and San Diego, CA, USA, August 7, 2018; 08:45 [...]

Shire plc : Rule 2.9 Announcement

07/08/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 7 August 2018 [...]

Verona Pharma plc Operational Update and Financial Results for the Three and Six Months Ended June 30, 2018

07/08/2018 - 08:00

Significant progress with RPL554 as potential treatment for COPD and CF Recently initiated important Phase 2 trial as add-on to dual bronchodilator therapy for COPD maintenance treatment LONDON, Aug. 07, 2018 (GLOBE [...]

MDxHealth (R): MDxHealth Shareholder Transparency Declaration

07/08/2018 - 07:01

Press Release Regulated information 7 August 2018, 7.00 p.m. CET HERSTAL, BELGIUM and IRVINE, CA - August 7, 2018 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" or the "Company"), announced that it received on [...]

MDxHealth (R) : MDxHealth: Déclaration de Transparence d'un Actionnaire

07/08/2018 - 07:01

C ommuniqué de presse Information réglementée 7 août 2018, 07h00 HEC IRVINE, CA, et HERSTAL (BELGIQUE) - le 7 août 2018 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" ou la "Société"), a annoncé avoir reçu le 3 [...]

Syneos Health Announces Pricing of Secondary Offering of Common Stock

07/08/2018 - 02:01

RALEIGH, N.C., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), a leading biopharmaceutical solutions organization combining a CRO (Contract Research Organization [...]